HSF1 and HSF5 were highly expressed, while HSF2 and HSF4 were decreased in AML compared to healthy controls, and elevated expression of HSF1 has prognostic significance, indicating a worse survival probability, which has the potential to be a prognosis–predicted biomarker. This evidence concerns the gene HSF4 and acute myeloid leukemia.